Search
Spotlight
The OncLive Insider app is live!
CME Opportunities
The OncLive Insider app is live!
CME Opportunities
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
OncClub
All Oncology News
Media
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Partners
Publications
Resources
Consensus Viewpoints
OncLive App
Interactive Tools
Sponsored
Consensus Viewpoints
OncLive App
Interactive Tools
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
The OncLive Insider app is live!
CME Opportunities
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Extensive Stage Small-Cell Lung Cancer
EP. 1: Current Frontline Management of Small Cell Lung Cancer
December 17th 2019
EP. 2: Small Cell Lung Cancer: Interpreting Data From IMpower133
December 17th 2019
EP. 3: Results From the CASPIAN Trial in SCLC
December 17th 2019
EP. 4: Frontline I-O Strategies in SCLC: Practical Implications
December 17th 2019
EP. 5: I-O Strategies in Relapsed/Refractory SCLC
December 17th 2019
EP. 6: Small Cell Lung Cancer: Future Directions in Care
December 17th 2019
EP. 7: The Initial Approach to SCLC Treatment
December 17th 2019
EP. 8: SCLC Therapy: First-line Options Prior to Immunotherapy
December 17th 2019
EP. 9: Checkpoint Inhibitors in Second and Third-line
December 17th 2019
EP. 10: Negative I/O Trials: CheckMate331 and CheckMate 451
December 17th 2019
EP. 11: Immunotherapy Toxicity Profile
December 17th 2019
EP. 12: First-line Immunotherapy: IMPower133 Regimen
December 17th 2019
EP. 13: Frontline Therapy Approaches for Small Cell Lung Cancer
December 17th 2019
EP. 14: Immunotherapy in Relapsed-Refractory SCLC
December 17th 2019
EP. 15: The CASPIAN Trial in Extensive-Stage SCLC
December 17th 2019
EP. 16: The ADRIATIC Trial in Limited-Stage SCLC
December 17th 2019
EP. 17: Frontline and R/R Therapy and PD-L1 Targeted Therapy for SCLC
December 17th 2019
EP. 18: Emerging Therapies for Extensive Stage SCLC and CASPIAN Trial
December 17th 2019
EP. 19: Novel Agents for R/R and the Future of Extensive Stage SCLC
December 17th 2019
EP. 20: I/O Combination Regimens & the Importance of Biomarkers
December 17th 2019
NEXT PAGE
<
1
2
>
PREVIOUS PAGE
x
